Galderma Group AG (GALD) Price & Analysis

Compare

13 Followers

GALD Stock Chart & Stats

CHF154.60

-CHF8.02(-7.15%)

At close: Mar 06 4:00 PM EST

CHF154.60

-CHF8.02(-7.15%)

Day’s Range― - ―

52-Week RangeCHF72.70 - CHF170.10

Previous CloseN/A

Volume230.69K

Average Volume (3M)337.59K

Market Cap

CHF36.30B

Enterprise ValueCHF38.69B

Total Cash (Recent Filing)CHF458.00M

Total Debt (Recent Filing)CHF2.85B

Price to Earnings (P/E)52.9

Beta0.69

Next Earnings

Jul 23, 2026

EPS Estimate

1.93

Next Dividend Ex-DateN/A

Dividend Yield0.09%

Share Statistics

EPS (TTM)1.58

Shares Outstanding237,897,630

10 Day Avg. Volume210,266

30 Day Avg. Volume337,589

Financial Highlights & Ratios

PEG Ratio-0.19

Price to Book (P/B)3.07

Price to Sales (P/S)5.38

P/FCF Ratio112.22

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

CHF193.00

Price Target Upside24.84% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering8

EPS Forecast (FY)4.59

Revenue Forecast (FY)CHF6.23B

Bulls Say, Bears Say

Bulls Say

Earnings And Currency EffectsReported results modestly beating consensus, supported by favorable foreign exchange movements and guidance that implies modest upgrades, point to potential upward revisions to revenue and profit forecasts.

Product Launch MomentumAnalyst expects management to raise peak sales guidance for Nemluvio as international launches are outperforming United States rollouts, indicating stronger global demand than currently assumed.

Strategic PartnershipL'Oreal increasing its stake and potential board nominations are viewed as strategic validation that may accelerate research collaborations and broaden commercial reach in aesthetic markets.

Bears Say

Derma Skincare UnderperformanceUnderperformance in the Derma Skincare division represents a tangible headwind that could restrain overall revenue growth and limit segment margin improvement.

Injectable Aesthetics CautionHeightened caution around the Injectable Aesthetics segment may pressure sales projections and reduce confidence in near-term revenue momentum.

Galderma Group AG News

Hold Rating Maintained as Supportive FY26 Guidance Offers Limited Upside Versus High Expectations and Valuation

Morgan Stanley analyst Thibault Boutherin maintained a Hold rating on Galderma Group AG today and set a price...

7d ago

Buy Rating Backed by Strong Q4 Performance, Upgraded Nemluvio Outlook, and Enhanced 2026 Guidance Upside

Analyst Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG and keeping the price...

7d ago

Buy Rating on Galderma: Leading Global Skin‑Health Platform with Diversified Growth and Undervalued Upside

Galderma Group AG (GALD) has received a new Buy rating, initiated by H.C. Wainwright analyst, Ram Selvaraju. Ram...

10d ago

Galderma Buy Rating Underpinned by Strengthened CFO Leadership and Strategic Growth Prospects

Galderma Group AG, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Benjamin Jackson...

24d ago

Galderma Group AG: Buy Rating Driven by Underappreciated Nemluvio Peak Sales and Pipeline Upside

Benjamin Jackson CFA, an analyst from Jefferies, maintained the Buy rating on Galderma Group AG. The associated price...

1M ago

Galderma Group AG: Buy Rating Reaffirmed with 19% Price Target Increase Amid Strong Nemluvio Growth Projections

Analyst Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG and increased the price...

3M ago

Strategic Partnership and Stake Increase Drive Positive Outlook for Galderma: Buy Recommendation

Jefferies analyst Benjamin Jackson CFA has maintained their bullish stance on GALD stock, giving a Buy rating today....

3M ago

Galderma Group AG: Promising Growth Outlook and Strategic Expansion Drive Buy Rating

Analyst Benjamin Jackson CFA of Jefferies maintained a Buy rating on Galderma Group AG, retaining the price target...

4M ago

Galderma Group AG: Promising Growth Potential and Strategic Market Positioning Drive Buy Rating

Analyst Benjamin Jackson CFA from Jefferies maintained a Buy rating on Galderma Group AG and keeping the price...

5M ago

Galderma Group AG: Strong Q3 Performance Amid Market Challenges, Hold Rating Reflects Balanced Outlook

Analyst Thibault Boutherin from Morgan Stanley maintained a Hold rating on Galderma Group AG and keeping the price...

5M ago

GALD FAQ

What was Galderma Group AG’s price range in the past 12 months?

Galderma Group AG lowest stock price was CHF72.70 and its highest was CHF170.10 in the past 12 months.

What is Galderma Group AG’s market cap?

Galderma Group AG’s market cap is CHF36.30B.

When is Galderma Group AG’s upcoming earnings report date?

Galderma Group AG’s upcoming earnings report date is Jul 23, 2026 which is in 133 days.

How were Galderma Group AG’s earnings last quarter?

Galderma Group AG released its earnings results on Mar 05, 2026. The company reported CHF1.575 earnings per share for the quarter, beating the consensus estimate of CHF1.223 by CHF0.352.

Is Galderma Group AG overvalued?

According to Wall Street analysts Galderma Group AG’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Galderma Group AG pay dividends?

Galderma Group AG pays a Notavailable dividend of CHF0.15 which represents an annual dividend yield of 0.09%. See more information on Galderma Group AG dividends here

What is Galderma Group AG’s EPS estimate?

Galderma Group AG’s EPS estimate is 1.93.

How many shares outstanding does Galderma Group AG have?

Galderma Group AG has 237,897,630 shares outstanding.

What happened to Galderma Group AG’s price movement after its last earnings report?

Galderma Group AG reported an EPS of CHF1.575 in its last earnings report, beating expectations of CHF1.223. Following the earnings report the stock price went up 6.975%.

Which hedge fund is a major shareholder of Galderma Group AG?

Currently, no hedge funds are holding shares in CH:GALD

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Galderma Group AG

Galderma Group AG is engaged in cosmetic industry. Its segment includes Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology.

Galderma Group AG (GALD) Earnings & Revenues

Historic Earnings Reports

GALD Stock 12 Month Forecast

Average Price Target

CHF193.00

▲(24.84% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"94":"CHF94","261":"CHF261","135.75":"CHF135.8","177.5":"CHF177.5","219.25":"CHF219.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":260,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF260.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":193,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF193.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":155,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF155.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[94,135.75,177.5,219.25,261],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,147.6,156.24615384615385,164.8923076923077,173.53846153846155,182.18461538461537,190.83076923076925,199.47692307692307,208.12307692307692,216.76923076923077,225.41538461538462,234.06153846153848,242.7076923076923,251.35384615384618,{"y":260,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,147.6,151.09230769230768,154.58461538461538,158.07692307692307,161.56923076923076,165.06153846153845,168.55384615384617,172.04615384615386,175.53846153846155,179.03076923076924,182.52307692307693,186.01538461538462,189.5076923076923,{"y":193,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,147.6,148.16923076923075,148.73846153846154,149.3076923076923,149.87692307692308,150.44615384615383,151.01538461538462,151.58461538461538,152.15384615384616,152.72307692307692,153.2923076923077,153.86153846153846,154.43076923076924,{"y":155,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":109.76,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.27,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":95.9,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":110.7,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":115.5,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":127.5,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":139.9,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":134.7,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":158.1,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":162.1,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":147.6,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >